Sarepta Therapeutics stock quoted at EUR 15.99 in latest indication
Published on 11/08/2026 at 14:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSarepta's Latest Company Communications
- Sarepta's investor-relations page lists third-quarter 2026 results and recent corporate developments.
- Recent company communications also cover Sarepta's neuromuscular medicine portfolio.
Sarepta Therapeutics stock traded at EUR 15.99 on Lang & Schwarz at 13:04 CET on Saturday, November 7, 2026. Investors can follow the real-time quote of Sarepta Therapeutics stock.
The latest company communications are listed on Sarepta's investor-relations press-release page. The page includes the company's third-quarter 2026 financial results and recent corporate developments, published on November 5, 2026.
Company updates remain in focus
The same page also lists a November 2026 investor-conference announcement and recent communications on Sarepta's neuromuscular medicine portfolio. Those releases keep clinical development and financial performance central to the company's investor agenda.
Sarepta Therapeutics stock
- Company: Sarepta Therapeutics, Inc.
- ISIN: US8036071004
- Ticker: SRPT
- Latest quote: EUR 15.99
- Quote time: 13:04 CET, Saturday, November 7, 2026
- Trading venue: Lang & Schwarz
US equities remain part of the broader market picture covered in current S&P 500 market reports.
More company-specific coverage is available in more news and analyses on Sarepta Therapeutics stock.
